îæ€çŽ¢
îæ€çŽ¢
î
Nervgen Pharma Ord Shs
NGENîãŠã©ãããªã¹ãã«è¿œå
3.565USD
-0.145-3.91%
çµå€Â 05/15, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
287.12Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± Nervgen Pharma Ord Shs äŒæ¥å
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
Nervgen Pharma Ord Shsã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãNGEN
äŒç€ŸåNervGen Pharma Corp
äžå Žæ¥Mar 13, 2019
æé«çµå¶è²¬ä»»è
ãCEOãRogers (Adam H)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
決ç®ææ«- -
æ¬ç€Ÿæåšå°Suite 1703 - 595 Burrard Street
éœåžVANCOUVER
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœCanada
éµäŸ¿çªå·V7X 1J1
é»è©±çªå·16047225361
ãŠã§ããµã€ãhttps://www.nervgen.com/
äŒæ¥ã³ãŒãNGEN
äžå Žæ¥Mar 13, 2019
æé«çµå¶è²¬ä»»è
ãCEOãRogers (Adam H)
Nervgen Pharma Ord Shsã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
160.00K
-31.25%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
27.76K
-54.04%
,
,
--
--
Mr. Brian Eric Bayley
Mr. Brian Eric Bayley
Independent Director
Independent Director
--
--
Dr. Harold Martin Punnett
Dr. Harold Martin Punnett
Independent Director
Independent Director
--
--
Mr. William J. (Bill) Adams
Mr. William J. (Bill) Adams
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. Daniel D. (Dan) Mikol, M.D., Ph.D
Dr. Daniel D. (Dan) Mikol, M.D., Ph.D
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John Craig Thompson
Mr. John Craig Thompson
Independent Director
Independent Director
--
--
Dr. Adam H. Rogers
Dr. Adam H. Rogers
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Gianni (John) Ruffolo
Mr. Gianni (John) Ruffolo
Independent Director
Independent Director
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
160.00K
-31.25%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
27.76K
-54.04%
,
,
--
--
Mr. Brian Eric Bayley
Mr. Brian Eric Bayley
Independent Director
Independent Director
--
--
Dr. Harold Martin Punnett
Dr. Harold Martin Punnett
Independent Director
Independent Director
--
--
Mr. William J. (Bill) Adams
Mr. William J. (Bill) Adams
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Thu, May 14
æŽæ°æå»: Thu, May 14
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
PFP Biosciences Holdings LLC
18.24%
Punnett, Harold
1.46%
Bayley (Brian E)
0.70%
Kaye (Randall E)
0.20%
Valley Forge Investment Consultants, Inc.
0.10%
ä»ã®
79.31%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
PFP Biosciences Holdings LLC
18.24%
Punnett, Harold
1.46%
Bayley (Brian E)
0.70%
Kaye (Randall E)
0.20%
Valley Forge Investment Consultants, Inc.
0.10%
ä»ã®
79.31%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Other Insider Investor
18.24%
Individual Investor
2.51%
Investment Advisor
0.61%
Bank and Trust
0.05%
Investment Advisor/Hedge Fund
0.04%
Hedge Fund
0.03%
ä»ã®
78.52%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Fri, Jan 9
æŽæ°æå»: Fri, Jan 9
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
17
350.93K
0.44%
+303.13K
2025Q4
2
--
0.00%
-47.80K
2025Q3
2
--
0.00%
-47.80K
2025Q2
2
--
0.00%
-47.80K
2025Q1
2
--
0.00%
-47.80K
2024Q4
2
--
0.00%
-47.80K
2024Q3
2
--
0.00%
-47.80K
2024Q2
3
44.40K
0.06%
-41.20K
2024Q1
2
3.40K
0.01%
-30.00K
2023Q4
2
3.40K
0.01%
-30.00K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
PFP Biosciences Holdings LLC
14.69M
18.24%
+1.81M
+14.05%
Nov 19, 2025
Punnett, Harold
1.18M
1.46%
+50.00K
+4.44%
Jul 18, 2025
Bayley (Brian E)
565.00K
0.7%
+250.00K
+79.37%
Nov 19, 2025
Kaye (Randall E)
160.00K
0.2%
+50.00K
+45.45%
Jan 04, 2026
Ruffolo (John)
70.41K
0.09%
--
--
Mar 28, 2025
Mckerracher (Krista L)
49.76K
0.06%
-10.00K
-16.73%
Mar 02, 2026
詳现ãèŠã
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
